Stock Information

• Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing
  Tue, Mar 31, 2026 9:50 PM
• Gilead Sciences Shows Solid Early Yeztugo Persistence but Limited Market Expansion, RBC Says
  Tue, Mar 31, 2026 3:19 PM
• Gilead Sciences, Inc. (GILD) M&A Call Transcript
  Tue, Mar 31, 2026 2:12 PM
• Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials
  Tue, Mar 31, 2026 1:26 PM
• Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration
  Tue, Mar 31, 2026 8:16 AM
• Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
  Tue, Mar 31, 2026 5:30 AM
• Galapagos And Gilead Collaborate On Ouro's $1.675B Acquisition, Retaining $500M Cash With Up To $150M Return To Shareholders
  Tue, Mar 31, 2026 1:39 AM
• $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
  Mon, Mar 30, 2026 12:45 PM
• Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks
  Sat, Mar 28, 2026 3:50 AM
• Why Gilead Sciences (GILD) Dipped More Than Broader Market Today
  Fri, Mar 27, 2026 10:00 PM

Financial data not available